Results 121 to 130 of about 17,905 (230)

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. [PDF]

open access: yes, 2016
The fungal pathogen Candida glabrata has emerged as a major health threat since it readily acquires resistance to multiple drug classes, including triazoles and/or echinocandins.
Alexander, B.D.   +12 more
core   +1 more source

Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition [PDF]

open access: yes, 2018
Candidiases are the most recurrent fungal infections, especially among immunosuppressed patients. Although Candida albicans is still the most widespread isolated species, non-Candida albicans Candida species have been increasing.
Arendrup MC   +9 more
core   +1 more source

Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment

open access: yesJournal of Fungi, 2019
This paper reviews recent advances in three selected areas of pediatric invasive candidiasis: epidemiology, diagnosis, and treatment. Although the epidemiological trends of pediatric invasive candidiasis illustrate a declining incidence, this infection ...
Thomas J. Walsh   +4 more
doaj   +1 more source

Sunflower Oil and Cholesterol Nanoemulsion: A Novel Carrier for Micafungin to Combat Multi-Resistant Candida auris

open access: yesPathogens
Candida auris is an emerging, multidrug-resistant yeast that causes systemic infections, mainly in hospitalized or immunosuppressed patients. This pathogen has a high mortality and morbidity rate.
Gabriel Davi Marena   +12 more
doaj   +1 more source

Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms [PDF]

open access: yes, 2019
Bozó, Aliz   +7 more
core   +1 more source

Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. [PDF]

open access: yes, 2009
Experience with anidulafungin against Candida krusei is limited. Immunosuppressed mice were injected with 1.3 x 10(7) to 1.5 x 10(7) CFU of C. krusei.
Chen, Enuo   +4 more
core  

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications

open access: yesFrontiers in Pharmacology
Echinocandins, a prominent class of antifungals, are known for their broad-spectrum activity and favorable safety profiles. However, their bioavailability and efficacy via oral route are suboptimal. In this study, caspofungin and micafungin, the two most
Sepideh Mehravar   +5 more
doaj   +1 more source

Successful treatment of a fluconazole low-susceptibility <i>Kodamaea ohmeri</i> bloodstream infection with micafungin: A case report and literature review. [PDF]

open access: yesIDCases
Hirayama S   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy